IDEX Corporation: Steridose & Magnetic Mixers
Former Sales Manager at Steridose an IDEX Corporation subsidiary
inpractise.com/articles/idex-corporation-steridose-and-magnetic-mixers
Former Sales Manager at Steridose an IDEX Corporation subsidiary
Interview Transcript
This is a snippet of the transcript, sign up to read more.
Do you have any estimate of the growth rate over a decade, say from 2010 to 2020?
Yes, looking at Steridose, from the beginning, going back to 2005, I would estimate it was around 2 million euros at the time, not considering exchange rates. It grew to 9 or 10 million by the time I left.
This is a snippet of the transcript, sign up to read more.
Can you say if it was more like 20, 40, or 50 plus percent? Just indicative, probably hard to judge?
It would be hard to judge, but maybe it could be somewhere around 30. It wouldn't feel strange if a third of sales came from spare parts. It's also hard to distinguish because sometimes when you have a customer, some of it could still be from small expansions or they need to replace a whole vessel. So, is it new sales or is it spare parts? It is for the already installed base. But somewhere around there, I would say.
This is a snippet of the transcript, sign up to read more.
Related Content
IDEX Corporation: Culture & the 80/20 Principle
Former VP at Idex Corporation
IDEX Corporation: M&A strategy & Operating model
Former Idex Corporation President
IDEX: Health & Science Division History
Former Senior Executive at IDEX Health & Science
Graco: Culture, Sales, & Distribution
Former Global Vice President at Graco
Copyright Notice
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.